Cart
sales@molnova.com
DSS30
CAS No. 883027-32-5
DSS30( —— )
Catalog No. M35558 CAS No. 883027-32-5
DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 282 | In Stock |
|
| 5MG | 472 | In Stock |
|
| 10MG | 644 | In Stock |
|
| 25MG | 905 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDSS30
-
NoteResearch use only, not for human use.
-
Brief DescriptionDSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).
-
DescriptionDSS30 is a P25/CDK5 inhibitor that reduces β-amyloid (Aβ) secretion by inhibiting amyloid precursor protein lyase 1 (BACEl) phosphorylation. DSS30 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
-
In VitroDSS30 (50 μM, 2 hours) inhibits the activity of the P25/CDK5 complex by up to 50% and the phosphorylation of BACE1 or Tau.Western Blot Analysis Cell Line:Expressed P25 PC12tet-off cell lines Concentration:50 μM Incubation Time:8 hours Result:Inhibited BACE1 phosphorylation by 12%.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
RecptorBeta Amyloid | CDK | BACE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number883027-32-5
-
Formula Weight367.87
-
Molecular FormulaC16H14ClNO3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=2C(SC1S(NC3=C(OC)C=CC=C3)(=O)=O)=CC=C(Cl)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sul-Hee Chung, et al. Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease. WO2006075808
molnova catalog
related products
-
δ-secretase inhibito...
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
-
Methyl tridecanoate
Methyl tridecanoate inhibits β-amyloid aggregation moderately and inhibits acetylcholinesterase (AChE) weekly.
-
β-Amyloid 18-28
Intracerebroventricular administration of synthetic peptides Beta-amyloid (12-20), (12-28), and (18-28) causes amnesia in mice. These peptides have only amino acid residues VFF at position 18 to 20 in common, suggesting the amnestic effect of the triad.
